Gregory Enns, M.D.
Dr. Enns is a Professor of Pediatrics and Director of the Biochemical Genetics Program at Stanford University. After receiving his medical degree from the University of Glasgow, he trained in Pediatrics at Children's Hospital Los Angeles, and in Clinical Genetics and Clinical Biochemical Genetics at the University of California, San Francisco.
He has extensive experience in the diagnosis and management of inborn errors of metabolism, including congenital disorders of glycosylation, mitochondrial disorders, and lysosomal storage disorders. Dr. Enns also performs translational research focusing on the development of a sensitive panel of redox biomarkers to study disorders of energy metabolism, and participates in clinical trials aimed at developing novel treatments for inborn errors of metabolism.
Hudson H. Freeze, Ph.D.
Hudson (Hud) Freeze is Professor of Glycobiology and Director of the Human Genetics Program at the Sanford-Burnham-Prebys Medical Discovery Institute in La Jolla, Calif. He came to UC San Diego in 1969 as a graduate student in the Biology Department, earning his Ph.D. in 1975. He was a faculty member of the UC San Diego School of Medicine from 1983-88 and remains as an adjunct professor. The last 26 years of his research focused on the identification and understanding of human genetic disorders, specifically the congenital disorders of glycosylation (CDG). His work contributed directly to the discovery of more than 145 CDGs. He collaborates closely with other glycobiologists, cell biologists, physicians, families, and their support organizations and regularly consults on CDG cases. He is passionate about communicating science to the public. In 1966, he isolated the first extreme thermophile, Thermus aquaticus (Taq), for which he won the 2013 Golden Goose Award for its revolutionary impact on biotechnology and medicine.